Skip to main content
. 2021 Feb 12;9(2):184. doi: 10.3390/biomedicines9020184

Table 2.

Possible biomarkers used for the detection of hepatocellular carcinoma (HCC).

Biomarker Role in HCC Development
Osteopontin Glycoprotein of the extracellular matrix, overly expressed in HCC
Dickkopf-1 Inhibitor of Wnt/β-catenin signaling, overly expressed in HCC
miR-122 Marker of liver injury; suppressed in HCC
GSTP1 Negatively correlated with tumor size and overall survival
RASSF1 Positively correlated with longer overall survival and better prognosis
LINE-1 Hypomethylation associated with shorter overall survival